A citation-based method for searching scientific literature

Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn, John M Lachin, Darren K McGuire, Michael J Pencina, Eberhard Standl, Peter P Stein, Shailaja Suryawanshi, Frans Van de Werf, Eric D Peterson, Rury R Holman. N Engl J Med 2015
Times Cited: 1525



Adrian F Hernandez, Jennifer B Green, Salim Janmohamed, Ralph B D'Agostino, Christopher B Granger, Nigel P Jones, Lawrence A Leiter, Anne E Rosenberg, Kristina N Sigmon, Matthew C Somerville, Karl M Thorpe, John J V McMurray, Stefano Del Prato. Lancet 2018
Times Cited: 621




List of shared articles



Times cited

Glycaemic Control and Vascular Complications in Diabetes Mellitus Type 2.
Francesco Maranta, Lorenzo Cianfanelli, Domenico Cianflone. Adv Exp Med Biol 2021
10


SGLT-2 inhibitors may be targeting higher risk patients with diabetes possibly justifying higher cost: Single center repeated cross-sectional analysis.
Larry A Weinrauch, Jiankang Liu, Alissa R Segal, Jason Woodward, John A D'Elia. J Diabetes Complications 2021
1



Therapies for the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes and Dyslipidemia.
María Aguilar-Ballester, Gema Hurtado-Genovés, Alida Taberner-Cortés, Andrea Herrero-Cervera, Sergio Martínez-Hervás, Herminia González-Navarro. Int J Mol Sci 2021
4


Glucose-Lowering Medications and Cardiovascular Outcomes.
Madhan Shanmugasundaram, J R Exequiel Pineda, Sangeetha Murugapandian. Curr Cardiol Rep 2021
1

The Safety of Pharmacological and Surgical Treatment of Diabetes in Patients with Diabetic Retinopathy-A Review.
Wojciech Matuszewski, Angelika Baranowska-Jurkun, Magdalena Maria Stefanowicz-Rutkowska, Katarzyna Gontarz-Nowak, Ewa Gątarska, Elżbieta Bandurska-Stankiewicz. J Clin Med 2021
0

Effects of anti-diabetes medications on cardiovascular and kidney outcomes in Asian patients with type 2 diabetes: a rapid evidence assessment and narrative synthesis.
Takashi Kadowaki, Fumiko Yamamoto, Yusuke Taneda, Yusuke Naito, Douglas Clark, Søren S Lund, Tomoo Okamura, Kohei Kaku. Expert Opin Drug Saf 2021
0

The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk.
Cyrielle Caussy, Adrien Aubin, Rohit Loomba. Curr Diab Rep 2021
2

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor.
Johanna Helmstädter, Karin Keppeler, Leonie Küster, Thomas Münzel, Andreas Daiber, Sebastian Steven. Br J Pharmacol 2021
1

Report from the CVOT Summit 2020: new cardiovascular and renal outcomes.
Oliver Schnell, Xavier Cos, Francesco Cosentino, Thomas Forst, Francesco Giorgino, Hiddo J L Heersprink, Mikhail Kosiborod, Christoph Wanner, Eberhard Standl. Cardiovasc Diabetol 2021
1

Diabetic heart disease: A clinical update.
Jake Rajbhandari, Cornelius James Fernandez, Mayuri Agarwal, Beverly Xin Yi Yeap, Joseph M Pappachan. World J Diabetes 2021
2

Cardiovascular Outcome Trials with Glucose-Lowering Drugs.
Tina K Thethi, Anika Bilal, Richard E Pratley. Curr Cardiol Rep 2021
1

CARDIOVASCULAR EFFECTS OF NON-INSULIN GLUCOSE-LOWERING AGENTS: A COMPREHENSIVE REVIEW OF TRIAL EVIDENCE AND POTENTIAL CARDIOPROTECTIVE MECHANISMS.
Gianluigi Savarese, Javed Butler, Lars H Lund, Deepak L Bhatt, Stefan D Anker. Cardiovasc Res 2021
1

Cardiovascular Outcomes Trials of Incretin-Based Therapies.
Tina K Thethi, Anika Bilal, Richard E Pratley. Diabetes Spectr 2021
0

Role of diabetes in stroke: Recent advances in pathophysiology and clinical management.
Sian A Bradley, Kevin J Spring, Roy G Beran, Dimitrios Chatzis, Murray C Killingsworth, Sonu M M Bhaskar. Diabetes Metab Res Rev 2021
0

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
Frank L J Visseren, François Mach, Yvo M Smulders, David Carballo, Konstantinos C Koskinas, Maria Bäck, Athanase Benetos, Alessandro Biffi, José-Manuel Boavida, Davide Capodanno,[...]. Eur J Prev Cardiol 2021
0

JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure.
Hiroyuki Tsutsui, Tomomi Ide, Hiroshi Ito, Yasuki Kihara, Koichiro Kinugawa, Shintaro Kinugawa, Miyuki Makaya, Toyoaki Murohara, Koichi Node, Yoshihiko Saito,[...]. Circ J 2021
1

Glucose-lowering therapy in patients undergoing percutaneous coronary intervention.
Isabelle Johansson, Ilaria Dicembrini, Edoardo Mannucci, Francesco Cosentino. EuroIntervention 2021
0

JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure.
Hiroyuki Tsutsui, Tomomi Ide, Hiroshi Ito, Yasuki Kihara, Koichiro Kinugawa, Shintaro Kinugawa, Miyuki Makaya, Toyoaki Murohara, Koichi Node, Yoshihiko Saito,[...]. J Card Fail 2021
0

Changing Fields-Diabetes Medications Invading the Cardiovascular Space.
Lauren D Breite, Mackenzie Steck, Brandon Tate Cutshall, Samarth P Shah, Brandon E Cave. Curr Probl Cardiol 2021
0

Optimizing Management of Type 2 Diabetes and Its Complications in Patients With Heart Failure.
Christie A Schumacher, Elizabeth K Van Dril, Kayce M Shealy, Jennifer D Goldman. Clin Diabetes 2021
0

Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy.
Amit K Rai, Brooke Lee, Ramesh Gomez, Deepu Rajendran, Mahmood Khan, Venkata Naga Srikanth Garikipati. Front Physiol 2021
1


Role of newer antidiabetic drugs on cardiovascular prevention and heart failure.
Jesús Miguel Rojas-Velázquez, Alejandro Giralt-Herrera, Jessica Leiva-Enríquez, Jennifer Leiva-Enríquez. Clin Investig Arterioscler 2021
0

Heart failure outcomes and glucagon-like peptide-1 receptor agonists: A systematic review of observational studies.
Omar S Alkhezi, Haifa A Alsuhaibani, Amal A Alhadyab, Mashael E Alfaifi, Basmah Alomrani, Ali Aldossary, Osamah M Alfayez. Prim Care Diabetes 2021
0

Interpretation of clinical trials on the cardiovascular effects of hypoglycemic drugs in people with type2 diabetes.
Ana Romero, Gemma Llauradó, José-Miguel González-Clemente. Endocrinol Diabetes Nutr (Engl Ed) 2021
0


Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community.
Adam J Nelson, Neha J Pagidipati, Vanita R Aroda, Matthew A Cavender, Jennifer B Green, Renato D Lopes, Hussein Al-Khalidi, Tanya Gaynor, Lisa A Kaltenbach, Julienne K Kirk,[...]. Circulation 2021
0